Sarepta Therapeutics (SRPT) option implied volatility increases into advisory committee meeting

Sarepta Therapeutics (NASDAQ: SRPT) 30-day option implied volatility is at 88; compared to its 52-week range of 39 to 84 into advisory committee meeting for SRP-9001 on May 12.

You May Also Be Interested In

• Varonis Systems (VRNS) 1500 contracts of June 70 calls trade, share price up 11.5%
• Cheniere Energy (LNG) call put ratio 17 calls 1 put with a focus on September 300 and 310 calls.
• Broadcom (AVGO) call put ratio 1.6 calls to 1 put into quarter results